Our Team
Management
Uday Khire
Co-founder, President & CEO
Dr. Khire co-founded AlloMek Therapeutics in 2011 based on discovery of novel macrocyclic MEK kinase inhibitor at Cheminpharma LLC, a drug discovery services company...read more
Barry Hart
Co-founder & Project Manager
Dr. Hart has over 15 years of leadership experience at pharmaceutical and biotechnology companies including Bayer, Scios, ViroBay, Inc. and...read more
Scott Kozak
Head, Licensing, Corporate & Business Development
Mr. Kozak brings more than 30 years of experience in the pharmaceutical industry in sales, marketing, brand...read more
Scientific Advisory Board
Prof. Howard Worman
MD, Columbia University Chair, SAB Board
Dr. Worman is a Professor of Medicine and Pathology and Cell Biology at Columbia university. Dr. Worman’s major research focus has been on the nuclear lamina and...read more
Georgia Sarquella-Brugada
Member, SAB Board
Dr. Georgia Sarquella-Brugada is senior pediatric cardiologist at the Sant Joan Deu Barcelona Children’s
Hospital. She received her M.D. from University of Barcelona...read more
Josep Brugada
Member, SAB Board
Dr. Brugada is a world-renowned cardiologist at the Hospital Clinic Barcelona at University of Barcelona. Dr. Josep Brugada, along with...read more
Board of Directors
Uday Khire
Co-founder, President & CEO
Dr. Khire co-founded AlloMek Therapeutics in 2011 based on discovery of novel macrocyclic MEK kinase inhibitor at Cheminpharma LLC, a drug discovery services company...read more
Daniel Wagner
Member of the Board
Dan serves as a Managing Director of Investments at Connecticut Innovations and is an active board member of multiple life sciences companies. Dan contributes to CI’s...read more
Jason Fisherman
Member of the Board
Jason S. Fisherman, MD, Dr. Fisherman has served as a director of AlloMek Therapeutics since June 2018. Dr. Fisherman is the President and CEO of Synkine...read more